Latest Period
Q4 2025
Security Snapshot
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) Institutional Ownership
CUSIP: 68621F102
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
146
Shares (Excl. Options)
69,508,758
Price
$5.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- ORGO on Nasdaq
- Shares outstanding
- 127,085,490
- Price per share
- $2.38
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 69,508,758
- Total reported value
- $359,879,905
- % of total 13F portfolios
- 0%
- Share change
- +714,444
- Value change
- +$3,812,134
- Number of holders
- 146
- Price from insider filings
- $2.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value is tracked under CUSIP 68621F102.
- 146 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 146 to 39 between Q4 2025 and Q1 2026.
- Reported value moved from $359,879,905 to $33,784,425.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 146 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 68621F102?
CUSIP 68621F102 identifies ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68621F102:
Significant Owners of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ades Alan A. | 18% | -1.1% | $66,289,913 | 22,319,836 | 0% | Alan A. Ades | 24 Jun 2025 | |
| NUSSDORF GLENN H | 9.7% | $51,688,923 | 12,248,560 | Glenn H. Nussdorf | 14 May 2025 | |||
| Soleus Capital Master Fund, L.P. | 7.9% | -20% | $42,040,854 | -$10,520,474 | 9,985,951 | -20% | Soleus Capital Master Fund, L.P. | 31 Dec 2025 |
| First Light Asset Management, LLC | 3.1% | -50% | $16,371,915 | -$18,610,675 | 3,888,816 | -53% | Mathew P. Arens | 31 Dec 2025 |
As of 31 Dec 2025, 146 institutional investors reported holding 69,508,758 shares of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO). This represents 55% of the company’s total 127,085,490 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) together control 49% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 9.2% | 11,638,836 | -1.3% | 0% | $60,289,171 |
| Soleus Capital Management, L.P. | 7.9% | 9,985,951 | -18% | 2.2% | $51,727,226 |
| Assenagon Asset Management S.A. | 4.4% | 5,535,334 | +14% | 0.04% | $28,673,030 |
| VANGUARD GROUP INC | 3.9% | 4,958,876 | -1.5% | 0% | $25,686,978 |
| BlackRock, Inc. | 3.7% | 4,761,094 | +3.8% | 0% | $24,662,466 |
| First Light Asset Management, LLC | 3% | 3,862,820 | -48% | 1.5% | $20,009,408 |
| DEUTSCHE BANK AG\ | 2.6% | 3,297,631 | +0.4% | 0.01% | $17,081,729 |
| DIMENSIONAL FUND ADVISORS LP | 2.1% | 2,730,980 | -6.1% | 0% | $14,146,476 |
| D. E. Shaw & Co., Inc. | 1.6% | 1,988,479 | +289% | 0.01% | $10,300,322 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 1,786,978 | +3.6% | 0% | $9,258,857 |
| STATE STREET CORP | 1.2% | 1,519,272 | -0.11% | 0% | $7,869,829 |
| ACADIAN ASSET MANAGEMENT LLC | 1.1% | 1,460,359 | -17% | 0.01% | $7,561,000 |
| NORGES BANK | 0.86% | 1,097,600 | 0% | $5,685,568 | |
| JANE STREET GROUP, LLC | 0.69% | 881,687 | +904% | 0.01% | $4,567,139 |
| RENAISSANCE TECHNOLOGIES LLC | 0.64% | 818,700 | -0.34% | 0.01% | $4,240,866 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.56% | 706,699 | -18% | 0% | $3,660,701 |
| AQR CAPITAL MANAGEMENT LLC | 0.5% | 641,523 | -9.2% | 0% | $3,323,089 |
| CITADEL ADVISORS LLC | 0.45% | 569,166 | 0% | $2,948,280 | |
| SG Americas Securities, LLC | 0.44% | 565,501 | +199% | 0% | $2,929,000 |
| NORTHERN TRUST CORP | 0.42% | 534,302 | -10% | 0% | $2,767,685 |
| BANK OF AMERICA CORP /DE/ | 0.41% | 525,810 | -14% | 0% | $2,723,696 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.38% | 487,667 | +21% | 0.01% | $2,526,115 |
| MILLENNIUM MANAGEMENT LLC | 0.38% | 483,742 | +481% | 0% | $2,505,784 |
| FLAX POND CAPITAL, LLC | 0.33% | 424,191 | 0% | 1.6% | $2,197,309 |
| RAYMOND JAMES FINANCIAL INC | 0.33% | 421,485 | +1.2% | 0% | $2,183,294 |
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 14,260,547 | $33,784,425 | -$11,205,261 | $2.37 | 39 |
| 2025 Q4 | 69,508,758 | $359,879,905 | +$3,812,134 | $5.18 | 146 |
| 2025 Q3 | 68,366,364 | $288,461,825 | -$3,867,059 | $4.22 | 119 |
| 2025 Q2 | 69,383,599 | $253,970,094 | +$15,169,482 | $3.66 | 113 |
| 2025 Q1 | 64,527,988 | $278,764,897 | +$10,290,470 | $4.32 | 135 |
| 2024 Q4 | 62,559,435 | $200,195,689 | -$4,632,565 | $3.20 | 119 |
| 2024 Q3 | 63,992,032 | $183,024,939 | +$3,073,151 | $2.86 | 111 |
| 2024 Q2 | 62,887,604 | $176,087,539 | +$15,313,422 | $2.80 | 114 |
| 2024 Q1 | 57,059,906 | $162,044,497 | -$4,218,961 | $2.84 | 123 |
| 2023 Q4 | 58,271,447 | $238,328,151 | +$24,483,565 | $4.09 | 107 |
| 2023 Q3 | 52,567,125 | $167,155,866 | +$2,434,079 | $3.18 | 103 |
| 2023 Q2 | 51,683,797 | $171,584,944 | -$2,458,393 | $3.32 | 111 |
| 2023 Q1 | 53,442,433 | $113,798,804 | -$5,356,219 | $2.13 | 130 |
| 2022 Q4 | 56,005,330 | $150,650,419 | +$1,931,028 | $2.69 | 146 |
| 2022 Q3 | 55,031,412 | $178,300,322 | -$19,442,671 | $3.24 | 144 |
| 2022 Q2 | 58,051,832 | $283,327,408 | -$3,172,672 | $4.88 | 140 |
| 2022 Q1 | 57,887,989 | $440,942,195 | +$10,319,977 | $7.62 | 147 |
| 2021 Q4 | 55,836,563 | $515,731,659 | -$2,571,363 | $9.24 | 151 |
| 2021 Q3 | 53,370,851 | $762,477,663 | +$42,467,188 | $14.24 | 141 |
| 2021 Q2 | 49,939,204 | $830,012,497 | +$410,032,084 | $16.62 | 140 |
| 2021 Q1 | 24,855,592 | $453,129,001 | +$68,036,540 | $18.22 | 99 |
| 2020 Q4 | 21,338,757 | $160,687,218 | +$122,816,812 | $7.53 | 65 |
| 2020 Q3 | 4,977,699 | $19,103,728 | +$2,285,403 | $3.84 | 47 |
| 2020 Q2 | 4,380,098 | $16,755,945 | +$2,234,312 | $3.84 | 47 |
| 2020 Q1 | 3,847,640 | $12,393,195 | -$1,227,774 | $3.23 | 50 |
| 2019 Q4 | 4,058,177 | $19,521,798 | +$10,098,739 | $4.81 | 53 |
| 2019 Q3 | 1,894,140 | $12,445,423 | +$1,959,070 | $6.57 | 37 |
| 2019 Q2 | 1,463,592 | $11,124,205 | +$4,972,528 | $7.60 | 27 |
| 2019 Q1 | 812,507 | $6,092,000 | +$6,092,000 | $7.50 | 16 |
| 2018 Q4 | $10.15 | 0 |